Press Releases

This summer, Aflac, the leader in voluntary insurance sales at U.S. worksites, is bringing My Special Aflac Ducks to Roswell Park Comprehensive Cancer Center. My Special Aflac Duck, designed by Sproutel, is a social robot that uses medical play, lifelike movement, and emotions to engage and help comfort kids during their cancer care. Today’s first-ever delivery to Roswell Park Comprehensive Cancer Center follows more than 18 months of child-centered research conducted with children, parents and medical providers at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta.

A scientist at Roswell Park Comprehensive Cancer Center has developed the first dedicated tool for analyzing a DNA-mapping technology known as ATAC-seq, a technique that identifies the gene “switches” responsible for cancer development and progression. Developed in collaboration with the University at Buffalo, the innovative computational method, named HMMRATAC, could vastly improve current methods of cancer detection and treatment.

At Sahlen Field, life is like a box of Mystery Balls – you never know what you’re going to get! The Buffalo Bisons are putting on their popular Mystery Ball Night on Tuesday, August 27 at Sahlen Field, in partnership with Roswell Park Comprehensive Cancer Center, as a night of hope and support for patients, survivors and caregivers.

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million. These competitive awards from both government agencies and private funders will fuel research to overcome obstacles in treating diseases like prostate, breast, colon and lung cancer, as well as less-common cancers like multiple myeloma and esophageal cancer. They include the first National Institutes of Health funding to study a new electronic tobacco device, plus new state funds from Empire State Development supporting Roswell Park’s role in the National Cancer Institute’s Cancer Moonshot initiative.

Roswell Park Comprehensive Cancer Center immunology researchers have uncovered a biomarker that may help explain why some patients respond better than others to a common chemotherapy treatment for liver cancer. They hope that their analysis of immune responses among patients receiving sorafenib can lead to more individualized treatment options and better overall outcomes for patients diagnosed with the disease.

A group of retired firefighters dedicated to raising funds for cancer research recently visited Roswell Park Comprehensive Cancer Center to make a significant donation that will go toward brain cancer research.

Researchers from Roswell Park Comprehensive Cancer Center have developed a new bioinformatics-based approach for monitoring key changes in cancer cells. They describe their work to develop this data-driven method and how it can be used to enhance and personalize cancer treatment in a recent article in the journal Nature Communications.

A record of outstanding clinical care and services has once again earned Roswell Park Comprehensive Cancer Center recognition as one of the top cancer hospitals in the country. The Buffalo-based cancer center has been named to U.S. News & World Report’s annual list of the Best Hospitals in the nation, and number 14 on its list of Best Hospitals for Cancer. U.S. News’ data-driven ranking places Roswell Park among the top 1.5% of cancer hospitals, and as a high-performing center in two subspecialty areas: colon cancer surgery and lung cancer surgery.

One of Roswell Park Comprehensive Cancer Center’s most distinguished researchers has been recognized again for his contributions to advance the fight against ovarian cancer. Ovarian Cancer Research Alliance (OCRA) awarded its Rosalind Franklin Prize for Excellence in Ovarian Cancer Research to Roswell Park Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, earlier this month during the organization’s 2019 Ovarian Cancer National Conference in Seattle, Washington.